EQL Pharma AB7JK 
$5.142.20%24h
2.20%24h
Global rank19063
Market cap$149.52M
Change 7d1.75%
YTD Performance62.81%
SP500 benchmarkOutperform
P/E4.95
P/S5.87
Revenue$25.45M
Earnings$3.03M
Dividend yield-
Main Sector
Healthcare
Category
EPS for EQL Pharma AB (7JK)
EQL Pharma AB has an EPS of $1.04. In 2022, the company made an earnings per share (EPS) of $1.09. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for 7JK
-
Value:-
EPS history for EQL Pharma AB from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | $1.04 | -4.59% |
| 2022 | $1.09 | 202.78% |
| 2021 | $0.36 | 286.51% |
| 2020 | $0.093141 | - |
View the highest EPS stocks
